Lille, France

Ve'ronique Leclerc

This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Ve'ronique Leclerc

Introduction

Ve'ronique Leclerc, based in Lille, France, is an accomplished inventor renowned for his significant contributions to the pharmaceutical field. With a deep understanding of medicinal chemistry, Leclerc has focused his research on developing innovative compounds that hold promise for treating various disorders.

Latest Patents

Leclerc holds a notable patent for tricyclic amide compounds. This invention pertains to benzofuran/pyran derivatives of a new tricyclic amide compound. These compounds are particularly relevant for their potential therapeutic applications in treating disorders of the melatoninergic system, showcasing the importance of his work in this specialized area of medicine.

Career Highlights

Leclerc is currently associated with Adir et Compagnie, where he continues his innovative research. His focus on applying chemical principles to create novel treatments demonstrates his commitment to advancing healthcare solutions.

Collaborations

Throughout his career, Leclerc has collaborated with esteemed colleagues such as Daniel Lesieur and Patrick Depreux. These partnerships have been instrumental in driving his research forward and ensuring the successful development of his patented compounds.

Conclusion

Ve'ronique Leclerc's dedication to innovation in the field of medicinal chemistry is evident through his patent and collaborative efforts. His work not only contributes to the scientific community but also holds the potential for improving therapeutic strategies for various melatoninergic disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…